Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
adverse drug reaction
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
asymptomatic
axonal degeneration
axonal transection
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
brain atrophy
brain volume
brainstem
brainstem, lesion of
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
children
controversies in neurology
cop 1
corpus callosum, lesion of
demyelinating disease
diabetes insipidus
diagnostic criteria
disability rating scale, neurological
disability, neurological
efficacy
Epstein-Barr virus
evoked potentials
fourth ventricle, shift of
gadolinium
gammaglobulin therapy, intravenous
hearing loss
hearing loss, sudden, unilateral
heralding manifestation
herpes virus
hydrocephalus
hydrocephalus, exvacuo
immunomodulation
immunosuppressive agents
interferon
interferon beta 1-a
interferon beta 1-b
intravenous
McDonald criteria for MS
misdiagnosis
mitoxantrone
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength
MRI, field strength, high
MRI, incidental finding
MRI, lesion burden
MRI, negative
MRI, optic nerve
MRI, serial
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
optic nerve, lesion of
optic neuritis
optic neuritis, etiology of
optic neuritis, treatment of
optical coherence tomography
periventricular leukomalacia
posterior fossa
posterior fossa, lesion of
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
protein 14-3-3, cerebrospinal fluid
review article
risk factors
safety
sensorineural hearing loss
serologic testing
spinal cord
spinal cord, lesion of
steroid
steroid therapy, CNS treatment and complications with
symmetric brain lesions
symptomatic
tinnitus
treatment of neurologic disorder
ventricular enlargement
viral infection
visual evoked response
white matter disease, periventricular
Showing articles 1050 to 1100 of 4024 << Previous Next >>

Decreased Hippocampal Volume Asymmetry on MRIs in Nondemented Elderly Subjects Carrying the Apolipoprotein E-4 Allele
Neurol 45:391-392, Soininen,H.,et al, 1995

Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995

Bilateral Simultaneous Optic Neuropathy in Adults:Clinical, Imaging, Serological, and Genetic Studies
JNNP 58:70-74, Morrissey,S.P.,et al, 1995

Optic Neuritis:A Population-Based Study in Olmsted County, Minnesota
Neurol 45:244-250, Rodriquez,M.,et al, 1995

Acute Viral Encephalitis in Childhood
BMJ 310:139-140, Kennedy,C., 1995

Neurodevelopmental Outcome of Infants with Hypoplastic Left Heart Syndrome
J Pediatr 126:496-498, Rogers,B.T.,et al, 1995

The Effect of Gadolinium on the Sensitivity and Specificity of MR in the Initial Diagnosis of Multiple Sclerosis
AJNR 16:259-264, Tas,M.W.,et al, 1995

Correlation Between Changes in Disability and T2-Weighted Brain MRI Activity in Multiple Sclerosis:A Follow-up Study
Neurol 45:255-260, Filippi,M.,et al, 1995

Acute Transverse Myelopathy:Spinal and Cranial MR Study with Clinical Follow-up
AJNR 16:115-123, Campi,A.,et al, 1995

Investigation of Peripheral Neuropathy
JNNP 58:274-283, McLeod,J.G., 1995

Focal Leptomeningeal MR Enhancement Along the Chiasm as a Presenting Sign of Multiple Sclerosis
J Comput Assist Tomogr 19:297-298, Demaerel,Ph.,et al, 1995

Patients with Multiple Sclerosis Presenting to Psychiatric Hospitals
J Clin Psychiatry 56:297-306, Pine,D.S.,et al, 1995

Spinal Multiple Sclerosis Mimicking a Spinal Cord Tumor:A Case Report
Neurological Surgery 23:1007-1010, Maezawa,H.,et al, 1995

Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995

Takayasu Arteritis
Ann Int Med 120:919-929, Kerr,G.S.,et al, 1994

Posttraumatic Headache
Semin Neurol 14:40-45, Packard,R.C., 1994

Mild Head Injury
(Ed) , Semin Neurol 14:1-9294., Packard,R.C., 1994

Regional Brain Abnormalities in Schizophrenia Measured with Magnetic Resonance Imaging
JAMA 272:1763-1769, Andreasen,N.C.,et al, 1994

Longitudinal MRI in Multiple Sclerosis:Correlation Between Disability and Lesion Burden
Neurol 44:2120-2124, Khoury,S.J.,et al, 1994

Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994

Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994

A Double-Blind, Placebo-Controlled Trial of Tizanidine in the Treatment of Spasticity Caused by Multiple Sclerosis
Neurol 44:S70-S78, Barnes,M.P.,et al, 1994

A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994

Neuroanatomy of Fragile X Syndrome:The Temporal Lobe
Neurol 44:1317-1324, Reiss,A.L.,et al, 1994

Reduced Basal Ganglia Volume Associated with the Gene for Huntington's Disease in Asymptomatic at-Risk Persons
Neurol 44:823-828, Aylward,E.H.,et al, 1994

The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Arch Neurol 51:505-516, Goodkin,D.E.,et al, 1994

Benign Form of Multiple Sclerosis:MRI Evidence for Less Frequent and Less Inflammatory Disease Activity
JNNP 57:1070-1072, Kidd,D.,et al, 1994

Quantitative Brain MRI Lesion Load Predicts the Course of Clinically Isolated Syndromes Suggestive of Multiple Sclerosis
Neurol 44:635-641, Felippi,M.,et al, 1994

Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994

The Hidden Costs of Medicolegal Abuses in Neurology
Arch Neurol 51:650-652, Scheinberg,P., 1994

Serial Neurologic Examinations After Near Drowning and Outcome
Arch Pediatr Adolesc Med 148:167-170, Bratton,S.L.,et al, 1994

Spontaneous Palpebromandibular Synkinesia:A Localizing Clinical Sign
Ann Neurol 35:222-228, Pullicino,P.M.,et al, 1994

Megadose Corticosteroids in Multiple Sclerosis
Neurol 44:1-4, Kupersmith,M.J.,et al, 1994

Chronic Spinal Cord Injury
NEJM 330:550-556, Ditunno,J.F.&Formal,C.S., 1994

A Randomized Trial of Test Result Sequencing in Patients with Suspected Multiple Sclerosis
Arch Neurol 51:53-59, O'Connor,P.,et al, 1994

Cerebrospinal Fluid in the Diagnosis of Multiple Sclerosis:A consensus Report
JNNP 57:897-902, Andersson,M.,et al, 1994

Prognosis of Young Adults with Ischemic Stroke:Follow-up Assessing Recurrent Vascular Events & Funct Outcome
Stroke 25:1360-1365, Kappelle,L.J.,et al, 1994

Value of Magnetic Resonance Imaging-Based Measurements of Hippocampal Formations in Patients with Partial Epilepsy
Arch Neurol 51:130-138, Adam,C.,et al, 1994

Interrater Agreement in Evaluation of Stroke Patients with the Unified Neurological Stroke Scale
Stroke 25:1263-1264, Treves,T.A.,et al, 1994

Deep Gray Matter Involvement in Children with Acute Disseminated Encephalomyelitis
AJNR 15:1275-1283, Baum,P.A.,et al, 1994

Breast Feeding and Multiple Sclerosis
BMJ 308:1411-1412, Pisacane,A.,et al, 1994

Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994

Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994

The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994

Balo Concentric Sclerosis:MR Diagnosis
AJNR 15:1284-1285, Korte,J.H.,et al, 1994

Dementia in 2 Histologically Confirmed Cases of MS:One Isolated Dementia & One Assoc with Psychiatric Symptoms
JNNP 57:353-359, Fontaine,B.,et al, 1994

The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994

Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994

Clin & Path Features of an Autosomal Dominant, Adult-Onset Leukodystrophy Simul Chronic Progressive MS
Arch Neurol 51:757-766, Schwankhaus,J.D.,et al, 1994

MR of Sarcoidosis in the Head and Spine:Spectrum of Manifestations and Radiographic Response to Steroid Therapy
AJNR 15:973-982, Lexa,F.J.&Grossman,R.I., 1994



Showing articles 1050 to 1100 of 4024 << Previous Next >>